Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Slack · SciRah

Researcher profile · Semantic Scholar

J. Slack

Share profile

J. Slack — researcher profile on SciRah

h-index: 29
Works: 119
Citations: 5,548

Most-cited papers

Decitabine improves patient outcomes in myelodysplastic syndromes
H. Kantarjian, Jean-Pierre J. Issa, Craig S. Rosenfeld, John M. Bennett +12 more
2006Cancer1,586 citations Open access
Semantic Scholar
Durable Remissions with Ivosidenib in IDH1‐Mutated Relapsed or Refractory AML
C. Dinardo, E. Stein, S. de Botton, G. Roboz +36 more
2018New England Journal of Medicine1,315 citations Open access
Semantic Scholar
Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial.
D. Steensma, M. Baer, J. Slack, R. Buckstein +7 more
2009Journal of Clinical Oncology328 citations Open access
Semantic Scholar
Financial burden in recipients of allogeneic hematopoietic cell transplantation.
N. Khera, Yu-Hui Chang, S. Hashmi, J. Slack +8 more
2013Biology of Blood and Marrow Transplantation132 citations Open access
Semantic Scholar
Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma
H. Paripati, A. Stewart, S. Cabou, A. Dueck +10 more
2008Leukemia132 citations
Semantic Scholar
A phase 2 study of vorinostat in acute myeloid leukemia
E. Schaefer, A. Loaiza-Bonilla, M. Juckett, J. Dipersio +6 more
2009Haematologica110 citations Open access
Semantic Scholar
Phase II multicenter study of arsenic trioxide in patients with myelodysplastic syndromes.
G. Schiller, J. Slack, J. Hainsworth, J. Mason +4 more
2006Journal of Clinical Oncology110 citations Open access
Semantic Scholar
Outcome of Hematopoietic Cell Transplantation for DNA-Double Strand Breakage Repair Disorders
J. Slack, M. Albert, D. Balashov, B. Belohradsky +47 more
2017Journal of Allergy and Clinical Immunology97 citations Open access
Semantic Scholar
RNAi screening of the kinome with cytarabine in leukemias.
R. Tibes, J. Bogenberger, L. Chaudhuri, R. T. Hagelstrom +10 more
2012Blood84 citations Open access
Semantic Scholar
Incidence and outcome of pancreatitis in children and young adults with acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003
S. Samarasinghe, S. Dhir, J. Slack, P. Iyer +4 more
2013British Journal of Haematology50 citations Open access
Semantic Scholar
Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phase.
Chad C Cherington, J. Slack, J. Leis, R. Adams +13 more
2012Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis47 citations
Semantic Scholar
Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis
T. Jain, K. Kunze, M. Temkit, Daniel K. Partain +11 more
2017Bone Marrow Transplantation46 citations Open access
Semantic Scholar
Allogeneic hematopoietic stem cell transplant overcomes the adverse survival effect of very high risk and unfavorable karyotype in myelofibrosis
A. Tefferi, Daniel K. Partain, J. Palmer, J. Slack +5 more
2018American journal of hematology/oncology44 citations Open access
Semantic Scholar
Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group.
M. Tallman, Haesook T. Kim, P. Montesinos, F. Appelbaum +22 more
2010Blood37 citations Open access
Semantic Scholar
Ivosidenib (AG-120) in Mutant IDH1 AML and Advanced Hematologic Malignancies: Results of a Phase 1 Dose Escalation and Expansion Study
C. Dinardo, S. de Botton, E. Stein, G. Roboz +28 more
201727 citations
Semantic Scholar
Integrated Systems and Technologies : Mathematical Oncology Dynamics of Leukemia Stem-like Cell Extinction in Acute Promyelocytic Leukemia
B. Werner, R. Gallagher, E. Paietta, M. Litzow +7 more
201427 citations
Semantic Scholar
A Phase II Study of Allogeneic Transplantation for Older Patients with AML in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results From CALGB 100103/BMT CTN 0502
S. Devine, K. Owzar, W. Blum, D. DeAngelo +17 more
201227 citations
Semantic Scholar
Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis
T. Jain, K. Kunze, L. Mountjoy, Daniel K. Partain +13 more
2020Blood Cancer Journal20 citations Open access
Semantic Scholar
Endothelial cell damage in idiopathic pneumonia syndrome
Thomas Altmann, J. Slack, M. Slatter, C. O'Brien +5 more
2018Bone Marrow Transplantation19 citations Open access
Semantic Scholar
Reduced toxicity conditioning and allogeneic stem cell transplantation in adults using fludarabine, carmustine, melphalan, and antithymocyte globulin: outcomes depend on disease risk index but not age, comorbidity score, donor type, or human leukocyte antigen mismatch.
J. Slack, A. Dueck, V. Fauble, L. Sproat +7 more
2013Biology of Blood and Marrow Transplantation18 citations Open access
Semantic Scholar
Clonal analyses of refractory testicular germ cell tumors
M. Barrett, Elzbieta Lenkiewicz, S. Malasi, M. Stanton +4 more
2019PLoS ONE17 citations Open access
Semantic Scholar
Impact of race and ethnicity on outcomes and health care utilization after allogeneic hematopoietic cell transplantation
N. Khera, Yu-Hui Chang, J. Slack, V. Fauble +10 more
2015Leukemia and Lymphoma17 citations
Semantic Scholar
Microbiologic yield of bronchoalveolar lavage specimens from stem cell transplant recipients
K. Sakata, Christine L Klassen, Kathryn Bollin, T. Grys +3 more
2017Transplant Infectious Disease13 citations Open access
Semantic Scholar
Single dose versus multiple doses of rituximab for preemptive therapy of Epstein–Barr virus reactivation after hematopoietic cell transplantation
T. Jain, H. Kosiorek, T. Grys, Shu T. Kung +8 more
2018Leukemia and Lymphoma12 citations
Semantic Scholar
Phase I/IB Study of Azacitidine and Hedgehog Pathway Inhibition with Sonidegib (LDE225) in Myeloid Malignancies
R. Tibes, H. Kosiorek, A. Dueck, J. Palmer +11 more
201712 citations
Semantic Scholar
Preliminary Results of a Phase II Study of Decitabine Administered Daily for 5 Days Every 4 Weeks to Adults with Myelodysplastic Syndrome (MDS).
D. Steensma, M. Baer, J. Slack, R. Buckstein +4 more
200711 citations
Semantic Scholar
Clinical outcomes with low dose anti-thymocyte globulin in patients undergoing matched unrelated donor allogeneic hematopoietic cell transplantation
Luke Mountjoy, T. Jain, K. Kunze, N. Khera +7 more
2020Leukemia and Lymphoma10 citations
Semantic Scholar
Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy
P. Agasthi, Hemalatha Narayanasamy, D. Sorajja, J. Slack +1 more
2018Case Reports in Cardiology10 citations Open access
Semantic Scholar
Nivolumab-associated bone marrow necrosis.
T. Hilal, P. Bansal, K. Kelemen, J. Slack
2018Annals of Oncology9 citations Open access
Semantic Scholar
Cytogenetic Evolution in Myeloid Neoplasms at Relapse after Allogeneic Hematopoietic Cell Transplantation: Association with Previous Chemotherapy and Effect on Survival.
Natalie M. Ertz-Archambault, H. Kosiorek, J. Slack, Melissa L Lonzo +3 more
2017Biology of Blood and Marrow Transplantation9 citations Open access
Semantic Scholar
Association of hematopoietic cell transplantation-specific comorbidity index with resource utilization after allogeneic transplantation
L. DeCook, Y. Chang, J. Slack, D. Gastineau +6 more
2017Bone Marrow Transplantation9 citations Open access
Semantic Scholar
Does early chimerism testing predict outcomes after allogeneic hematopoietic stem cell transplantation?
L. Mountjoy, J. Palmer, K. Kunze, N. Khera +5 more
2020Leukemia and Lymphoma8 citations Open access
Semantic Scholar
Efficacy of Mitoxantrone-Based Salvage Therapies in Relapsed or Refractory Acute Myeloid Leukemia in the Mayo Clinic Cancer Center: Analysis of Survival after CLAG-M Vs. MEC
C. Scheckel, M. Meyer, L. Mi, J. Slack +9 more
2018Blood7 citations Open access
Semantic Scholar
Phase I/IB Study of Azacitidine and Hedgehog Pathway Inhibition in Myeloid Malignancies
R. Tibes, H. Kosiorek, A. Dueck, Lisa Z. Sproat +10 more
20157 citations Open access
Semantic Scholar
A Phase 2 Study Of Lenalidomide, Rituximab, Cyclophosphamide and Dexamethasone (LR-CD) For Untreated Low Grade Non-Hodgkin Lymphoma Requiring Therapy: Waldenström’s Macroglobulinemia Cohort Results
A. Dueck, Katherine Gano, S. Ansell, C. Conley +26 more
20137 citations
Semantic Scholar
RNAi Screening Identifies BCL-XL As An Erythroid Lineage-Specific 5-Azacytidine Sensitizer While the BCL-2/BCL-XL/BCL-W Inhibitor ABT-737 Results in More Universal Sensitization in Leukemia Cells,
J. Bogenberger, Chang-xin Shi, I. Gonzales, R. Tiedemann +9 more
20117 citations
Semantic Scholar
Phase I Trial of a Novel Combination of An HDAC Inhibitor (LBH589) and An mTOR Inhibitor (RAD001) in Lymphoid and Plasma Cell Malignancies
Shaji K. Kumar, J. Mikhael, B. Laplant, J. Colgan +14 more
20116 citations
Semantic Scholar
Factors Affecting the Incidence of Severe (Stage 2-4) Gastrointestinal (GI) Graft-Versus-Host Disease (GVHD) in Adult Patients (pts) Undergoing Allogeneic Hematopoietic Transplant (Allo-HCT) for Hematologic Malignancy
J. Betcher, Yu-Hui Chang, P. Noel, J. Leis +5 more
20145 citations Open access
Semantic Scholar
Pretransplant body mass index on outcomes of allogeneic hematopoietic stem cell transplantation
Justin Tai, M. Buras, J. Leis, P. Noel +3 more
2019Bone Marrow Transplantation4 citations
Semantic Scholar
Ivosidenib (AG‐120) in Mutant IDH1 Relapsed/Refractory Acute Myeloid Leukemia: Results of a Phase 1 Study: AML‐221
C. Dinardo, E. Stein, S. de Botton, G. Roboz +36 more
2018Clinical Lymphoma, Myeloma & Leukemia4 citations Open access
Semantic Scholar
Feasibility and Impact of Digital Stories Intervention on Psychosocial Well-Being among Patients Undergoing Hematopoietic Cell Transplantation: A Pilot Study
S. Kim, L. Larkey, C. Meeker, Soojung Jo +11 more
20184 citations Open access
Semantic Scholar
Impact Of Vitamin D Level Pre and Post Allogeneic Hematopoietic Stem Cell Transplant
Kristen L. Beebe, J. Olsen, Yu-Hui Chang, Mary C. Burkhart +14 more
20134 citations
Semantic Scholar
Allogeneic stem cell transplantation in chronic myelomonocytic leukemia: analysis of post-transplant survival and risk factors in 138 Mayo Clinic patients
Ali Alsugair, Estefania Gauto Mariotti, Mohammad M. Alhousani, Saubia Fathima +23 more
2025Blood Cancer Journal3 citations Open access
Semantic Scholar
Ruxolitinib Prior to Allogeneic Stem Cell Transplant: The Experience at Mayo Clinic Arizona
V. Fauble, P. Noel, R. Mesa, R. Adams +6 more
20153 citations Open access
Semantic Scholar
Impact of lenalidomide therapy on stem cell mobilization in myeloma
H. Paripati, A. Stewart, R. Fonseca, A. Dueck +5 more
20083 citations
Semantic Scholar
Outcomes with Pre-Emptive Rituximab (pre-R) Treatment for Epstein-Barr Viremia (EBV) after Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
T. Jain, Ting-Kung Shu, H. Kosiorek, Vishal S. Shah +6 more
20172 citations Open access
Semantic Scholar
Day +30 and Day +100 CD33 Chimerisms Predict Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelofibrosis
T. Jain, M. Temkit, Daniel K. Partain, M. Patnaik +10 more
20162 citations
Semantic Scholar
A Phase II Clinical Trial of Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone (R-CyBor-D) in Relapsed Low Grade and Mantle Cell Lymphoma
A. Rosenthal, A. Dueck, Katherine Gano, C. Nichols +12 more
20142 citations
Semantic Scholar
A Phase I/II Combination Of RAD001 (Everolimus) and Lenalidomide For Relapsed Lymphoid Malignancy: Phase I Results
A. Dueck, Katherine Gano, C. Nichols, Ángela Toro +11 more
20132 citations
Semantic Scholar
A multicenter phase II trial of the decitabine alternative 5-day dosing regimen: Analysis of efficacy in various subgroups of patients with myelodysplastic syndromes (MDS)
D. Steensma, M. Baer, J. Slack, R. Buckstein +5 more
20082 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Leis×24
Invite
J. Leis — researcher profile on SciRah
P. Noel×19
Invite
P. Noel — researcher profile on SciRah
N. Khera×17
Invite
N. Khera — researcher profile on SciRah
Lisa Z. Sproat×17
Invite
Lisa Z. Sproat — researcher profile on SciRah

×16

Invite

J. Palmer — researcher profile on SciRah

Invite

V. Fauble — researcher profile on SciRah

Invite

C. Reeder — researcher profile on SciRah

Invite

A. Dueck — researcher profile on SciRah

Invite

R. Mesa — researcher profile on SciRah

H. Kantarjian×7

Invite

H. Kantarjian — researcher profile on SciRah

Invite

J. Mikhael — researcher profile on SciRah

Invite

T. Jain — researcher profile on SciRah